|

Air Purifier Use and Respiratory Health in COPD Patients

RECRUITINGN/ASponsored by Fudan University
Actively Recruiting
PhaseN/A
SponsorFudan University
Started2026-03-30
Est. completion2027-12
Eligibility
Age50 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07505602

Summary

This randomized, double-blind, parallel-controlled trial aims to evaluate the effects of an indoor air purifier intervention on respiratory health in patients with Chronic Obstructive Pulmonary Disease (COPD).

Eligibility

Age: 50 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age between 50 and 80 years old
* Physician diagnosis of COPD
* Living in Shanghai during the intervention period
* Subjects who have no plans to change homes during the intervention period
* Non-smokers and former smokers

Exclusion Criteria:

* Subjects living in a location other than home
* Subjects with a history of alcohol abuse
* Subjects with other chronic lung diseases, such as active tuberculosis, pulmonary fibrosis, cystic fibrosis, or alpha-1 antitrypsin deficiency
* Subjects with a history of thoracic surgery
* Subjects with a history of malignant tumors, such as lung cancer, liver cancer, or gastric cancer
* Subjects with diagnosed chronic hepatic or renal insufficiency, such as liver cirrhosis, chronic viral hepatitis, or autoimmune liver disease
* Subjects with acute myocardial infarction or unstable arrhythmia diagnosed within the past 6 weeks
* Subjects currently participating in other interventional studies

Conditions2

COPDRespiratory Health

Browse More Trials

COPD trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.